Hook
Posted Aug 6, 2026Video · 0:12by @cnbc
The video likely performed well due to the surprising and significant financial figure ($250 million) spent on a trending health topic (GLP-1 drugs), presented by a major CEO, which sparks curiosity and discussion.
The CEO of Bank of America states that the company spends $250 million annually on GLP-1 drugs for its employees, highlighting this as a significant investment in their workforce. This spending has increased substantially from zero just a few years prior.
Bank of America spends more than $250 million a year covering GLP-1 weight loss drugs for its employees, CEO Brian Moynihan told CNBC's "Squawk Box" on Wednesday, saying the rapidly rising cost is a worthwhile investment in his workforce. Read more at the #linkinbio or the link on screen. #CNBC #bankofamerica #glp1
CNBC SQUAWK BOX Bank of America CEO: We spend $250 million a year on GLP-1 drugs for our employees
Introduction of Bank of America CEO and topic
Statement on annual spending for GLP-1 drugs
Comparison to total healthcare spending
Emphasis on the recent increase in GLP-1 drug spending
CNBC: This is a media company that produces news content. It merely appears as a watermark and logo throughout the video. Removing it would not change what happens in the video. Bank of America: This is a financial institution. Its CEO is speaking in the video, and the company's spending on employee healthcare is the subject of the discussion. Removing the name would change the context of the video.
Read more at the #linkinbio or the link on screen.

Playing this video’s own audio, so you’ll hear the creator over the sound.
Promotes 12 products. Create free account to see more.
Outliers and viral hits: their videos on Overshot, all time.
What would you like the power to do? At Bank of America, our purpose is to help make financial lives better through the power of every connection.
All time.